Over the counter deals going over private equity's head

At €3.6bn, Waterland’s divestment of Belgium-based Omega Pharma in November was the second largest European trade sale of the year so far. Harriet Bailey asks if there is still room for the asset class in a sector dominated by big corporates with seemingly limitless balance sheets